Difficulty: Medium
Average Score: 84%
Practice
A 9-mo-old infant is recently diagnosed with bilateral retinoblastoma; examination under anesthesia reveals bilateral multifocal involvement of the retina. An important next step in the management is
Correct answer
B
Rationale
In the case of a 9-month-old infant diagnosed with bilateral retinoblastoma with multifocal involvement, the important next step in management is to conduct a retinal examination of 1st degree relatives (Option B). This is crucial because retinoblastoma is a genetic condition that can be hereditary. By examining the first-degree relatives, it helps in identifying any potential genetic predisposition in the family members which can guide further management and screening.
Option A, radiotherapy of both eyes, is not the preferred next step because radiotherapy may not be the best treatment option for retinoblastoma in young children due to potential long-term side effects on vision and development.
Option C, orbital ultrasonography, may not provide additional information relevant to the genetic predisposition in the family and may not be the most immediate next step in management.
Option D, bilateral enucleation, is a drastic step that should be considered only after all other treatment options have been explored. It is not the immediate next step in this scenario as it does not address the genetic component of the disease.
In an educational context, understanding the importance of genetic testing and family screening in cases of retinoblastoma is crucial for healthcare providers managing pediatric oncology cases. It emphasizes the need for a comprehensive approach that takes into consideration both the individual patient and their family history to provide the best possible care and outcomes.
Option A, radiotherapy of both eyes, is not the preferred next step because radiotherapy may not be the best treatment option for retinoblastoma in young children due to potential long-term side effects on vision and development.
Option C, orbital ultrasonography, may not provide additional information relevant to the genetic predisposition in the family and may not be the most immediate next step in management.
Option D, bilateral enucleation, is a drastic step that should be considered only after all other treatment options have been explored. It is not the immediate next step in this scenario as it does not address the genetic component of the disease.
In an educational context, understanding the importance of genetic testing and family screening in cases of retinoblastoma is crucial for healthcare providers managing pediatric oncology cases. It emphasizes the need for a comprehensive approach that takes into consideration both the individual patient and their family history to provide the best possible care and outcomes.